Results 51 to 60 of about 14,154 (120)
Evidence of dual sexual transmission of multi-resistant HIV with two years persistence of resistance to NRTI and NNRTI: a case report
, 2007 A case report of dual sexual transmission, with secondary transmission from naïve to naïve patient, of HIV harbouring K103N and L100I mutations, conferring full non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance, plus 2 nucleoside ...Mosti, S, Acinapura, R, Antinori, A., Ammassari, A, Marconi, P, Visco-Comandini, U, Perno, C, Zaccarelli, M, Sette, P, PERNO, CARLO FEDERICO, Visco Comandini, U, Antinori, A, Liuzzi, G, C. F. Perno, P. Sette, G. Liuzzi, S. Mosti, U. Visco-Comandini, A. Antinori, R. Acinapura, P. Marconi, A. Ammassari, M. Zaccarelli +22 morecore +1 more sourceEfficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL
, 2017 Nucleos(t)ide reverse transcriptase inhibitors (NRTI) toxicity may represent a threat for long-term success of combined antiretroviral therapy. Some studies have suggested a possible improvement of NRTI-related toxicity after switching to NRTI-sparing ...Miriam Lichtner, Lo Caputo Sergio, the Icona Foundation Study Group, Cozzi-Lepri, Alessandro, FRANCISCI, Daniela, Antinori, Andrea, Di Biagio, Antonio, Di Giambenedetto, Simona, Cozzi Lepri, Alessandro, Vincenzo Vullo, Claudio Maria Mastroianni, Rusconi, Stefano, BALDELLI, Franco, Nicola Gianotti, Alessandro Cozzi‐Lepri, Simona Di Giambenedetto, Stefano Bonora, Gianotti, Nicola, Madeddu, Giordano, Antonio Di Biagio, Andrea De Luca, Andrea Antinori, null null, De Luca, Andrea, Bonora, Stefano, Carbone, Alessia, Giordano Madeddu, Stefano Rusconi, Alessia Carbone, Alessandro Cozzi-Lepri +29 morecore +2 more sourcesComposition of the NRTI back-bone of the regimen started after the discontinuation of tenofovir (rows), according to the initial third drug (columns)–All tenofovir discontinuations.
, 2016 Composition of the NRTI back-bone of the regimen started after the discontinuation of tenofovir (rows), according to the initial third drug (columns)–All tenofovir discontinuations.Alessandro Cozzi-Lepri (195759), Stefano Bonora (237807), Antonella d’Arminio Monforte (2198545), Franco Maggiolo (372561), Massimo Galli (120466), Silvia Costarelli (3122250), Pierluigi Viale (463530), Giuseppe Lapadula (554894), Giordano Madeddu (483858), Andrea Gori (62770), Giovanni Di Perri (237806), Andrea Antinori (103654) +11 morecore +1 more sourceDifferential effects of nucleoside reverse transcriptase inhibitor (NRTI) regimens on adipocyte mitochondrial DNA depletion in HIV-infected patients
, 2004 BACKGROUND: Clinical trials data have provided strong evidence that NRTI therapy significantly influences risk of lipoatrophy. Here we examine associations between stavudine, zidovudine and non-thymidine NRTI regimens, as well as demographic and HIV ...McKinnon, E., Nolan, D., Hammond, E., James, I., Mallal, S. +4 morecore The prevalence of each NRTI-associated surveillance drug-resistance mutation in this meta-analysis versus in NRTI-experienced individuals in the same regions according to HIVDB.
, 2015 The Spearman’s rank correlation coefficient (rho) and the p-value are shown in each plot. The number of isolates from NRTI-experienced individuals were 4,522, 2,218, 4,164, and 13,522 for SSA, SSEA, Latin America/Caribbean, and the pooled upper-income ...Lynn Morris (7883), Kok Keng Tee (370999), Gonzalo Yebra (294031), Santiago Avila-Rios (3160959), Anne Derache (688002), Pontiano Kaleebu (62293), Morgane Rolland (25957), Gustavo Reyes-Terán (115886), Nicole Vidal (175028), Hiroshi Ichimura (718080), Amilcar Tanuri (7885), Charles A. B. Boucher (306753), Seiichiro Fujisaki (718078), Junko Hattori (406072), Michael P. Busch (116605), Vici Varghese (247778), Cyrille F. Djoko (329533), Nicaise Ndembi (703630), Wataru Sugiura (7879), Michael R. Jordan (146520), Herve Fleury (3212832), Sasisopin Kiertiburanakul (427725), Mariane A. Stefani (718083), Pierre Frange (333142), Diane Descamps (266281), P. Richard Harrigan (7889), Vincent V. Soriano (718082), Chunfu Yang (293864), Sung Soon Kim (147215), Africa Holguin (7876), Rongge Yang (391867), Marie-Laure Chaix (204736), Silvia Bertagnolio (57174), David Katzenstein (182035), Martine Peeters (50360), Somnuek Sungkanuparph (427731), David A. M. C. van de Vijver (363430), Hong-Ha M. Truong (342525), Toni T. D’Aquin (718075), Ramesh S. Paranjape (522326), Soo-Yon Rhee (42412), Jerome H. Kim (132312), Davey M. Smith (168770), Alaka K. Deshpande (718077), Radko Avi (437674), Raph L. Hamers (718072), Marcelo A. Soares (77938), Deogratius Ssemwanga (444460), Cillian F. De Gascun (718076), Matt A. Price (62305), Avelin F. Aghokeng (322582), Yanpeng Li (125043), Anne-Mieke Vandamme (7884), Jonathan Taylor (127703), Susan H. Eshleman (111762), Jan Albert (176517), Manon L. Ragonnet-Cronin (718081), Robert W. Shafer (32534), Tobias F. Rinke de Wit (178193), Bum Sik Chin (718074), Zabrina L. Brumme (178788), James I. Brooks (439423), Gillian M. Hunt (718079), Kee Peng NG (5662864), Pascal O. Bessong (718073), John P. A. Ioannidis (51405), Jose Luis Blanco (718071), Hermann Bussmann (250705), Mario Poljak (212447), Philippe Lemey (30422), Maja Stanojevic (550424), Irja Lutsar (437687), Sunee Sirivichayakul (7870) +72 morecore +1 more source